Glycomak 0.2mg Injection
Marketer
Makcur Laboratories Ltd.
Salt Composition
Glycopyrrolate (0.2mg)
Overview Glycomak 0.2mg Injection
Glycomak 0.2mg Injection, an anticholinergic agent, is administered pre- or intra-operatively to suppress secretions and counteract the neuromuscular blocking effects of certain surgical anesthetics. It also finds application in treating peptic ulcers in patients intolerant to oral therapies. Administration is solely by a physician or qualified nurse. Complete disclosure of all concurrent medications is crucial, as interactions are possible. Adherence to the prescribed treatment duration is vital; premature cessation may lead to symptom recurrence and disease exacerbation. Common adverse reactions include xerostomia, urinary retention, blurred vision, photosensitivity, mydriasis, cycloplegia, tachycardia, bradycardia, palpitations, elevated intraocular pressure, and decreased perspiration. Alcohol consumption should be avoided due to potential additive sedative effects. Patients with glaucoma, myasthenia gravis, congestive heart failure, or hypertension should inform their physician prior to treatment.
Uses of Glycomak 0.2mg Injection
Total Anesthesia | Gastric Ulceration
Major Benefits of Glycomak 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Glycomak 0.2mg Injection:
- Urinary retention
- Blurred vision
- Dilatation of pupil
- Cycloplegia (paralysis of the ciliary muscle of the eye)
- Ocular hyperemia
- Slow heart rate
- Palpitations
- Reduced sweating
- Increased heart rate
- Increased intraocular pressure
How to use Glycomak 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Glycomak 0.2mg Injection works:
Glycomak 0.2mg Injection, an anticholinergic agent, counteracts the effects of the neurotransmitter acetylcholine within the central nervous system.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Glycomak 0.2mg Injection's interaction with alcohol is undetermined. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Injection of Glycomak 0.2mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Glycomak 0.2mg Injection appears safe for breastfeeding mothers. Available human data indicates minimal risk to the infant. However, prolonged Glycomak 0.2mg Injection use may decrease breast milk supply.
DrivingUNSAFE
Administering Glycomak 0.2mg Injection may induce adverse reactions impacting driving capabilities. Glycomak 0.2mg Injection can impair vision and coordination, potentially compromising safe driving.
KidneyCAUTION
Administering Glycomak 0.2mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Glycomak 0.2mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Glycomak 0.2mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Glycomak 0.2mg Injection :
NA
Facts to Know About Glycomak 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Quaternary Ammonium Compounds (synthetic) |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Anesthesia and Anticholinergic Drugs |
3,018 People bought this recently